Search
Now showing items 1-1 of 1
Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation?
(2018)
BACKGROUND: Acute coronary syndrome (ACS) patients, despite treatment with dual antiplatelet therapy (DAPT), have up to 10% risk of recurrent major adverse cardiac events (MACE) in the short term. METHODS: Here we review ...